Tan KC - Search Results

1

Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus.

Tsun JG, Shiu SW, Wong Y, Yung S, Chan TM, Tan KC. Tsun JG, et al. Among authors: tan kc. Atherosclerosis. 2013 Dec;231(2):405-10. doi: 10.1016/j.atherosclerosis.2013.10.008. Epub 2013 Oct 18. Atherosclerosis. 2013. PMID: 24267259

2

Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria.

Tan K, Chow WS, Wong Y, Shiu S, Tam S. Tan K, et al. Diabetes Care. 2002 Jul;25(7):1254-5. doi: 10.2337/diacare.25.7.1254. Diabetes Care. 2002. PMID: 12087039 Clinical Trial. No abstract available.

3

Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y. Tan KC, et al. Eur J Clin Invest. 2003 Apr;33(4):301-6. doi: 10.1046/j.1365-2362.2003.01132.x. Eur J Clin Invest. 2003. PMID: 12662160

4

Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions.

Chen SP, Tan KC, Lam KS. Chen SP, et al. Among authors: tan kc. Atherosclerosis. 2003 Apr;167(2):287-92. doi: 10.1016/s0021-9150(03)00004-2. Atherosclerosis. 2003. PMID: 12818411 Free article.

5

Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages.

Lam MC, Tan KC, Lam KS. Lam MC, et al. Among authors: tan kc. Atherosclerosis. 2004 Dec;177(2):313-20. doi: 10.1016/j.atherosclerosis.2004.08.003. Atherosclerosis. 2004. PMID: 15530905

6

Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y, Tam S. Tan KC, et al. Atherosclerosis. 2005 Feb;178(2):365-70. doi: 10.1016/j.atherosclerosis.2004.09.005. Atherosclerosis. 2005. PMID: 15754464

7

HDL dysfunction in obstructive sleep apnea.

Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS. Tan KC, et al. Atherosclerosis. 2006 Feb;184(2):377-82. doi: 10.1016/j.atherosclerosis.2005.04.024. Epub 2005 Jun 21. Atherosclerosis. 2006. PMID: 15975582

8

Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y, Wong WK, Tam S. Tan KC, et al. Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):307-12. doi: 10.1002/dmrr.616. Diabetes Metab Res Rev. 2006. PMID: 16389649

9

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Tan KC, et al. Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13. Diabetologia. 2006. PMID: 16969649

10

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.

Tan KCB, Chow WS, Tso AWK, Xu A, Tse HF, Hoo RLC, Betteridge DJ, Lam KSL. Tan KCB, et al. Diabetologia. 2007 Sep;50(9):1819-1825. doi: 10.1007/s00125-007-0759-0. Epub 2007 Jul 18. Diabetologia. 2007. PMID: 17639302 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters